Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)
Author:
Trukhin Dmytro, Poddubskaya Elena, Andric Zoran, Makharadze Tamta, Bellala Ravi Shankar, Charoentum Chaiyut, Yañez Ruiz Eduardo P., Fulop Andrea, Hyder Ali Irfhan Ali, Syrigos Kostas, Katgi Nuran, Lopez Chuken Yamil Alonso, Rumyana Ilieva, Reyes-Igama Jasmin, Costamilan Rita de Cassia, Del Campo García AnaORCID, Florez Amalia, Paravisini Alexandra, Millan Susana, de Lima Araujo Luiz Henrique, de Oliveira Ferreira Carla Maria, Pinczowski Helio, Fernandes Monteiro Maria Marcela, Dudov Assen, Syrova Janeta, Orlandi Jorquera Francisco Javier, Gallardo Arenada Carlos Eduardo, Caglevic Medina Christian Lorenzo, Giorgadze Davit, Mchedlidze Nino, Kuchava Vladimer, Melkadze Tamar, Matitashvili Amiran, Chikhladze Nana, Samantas Epaminodas, Kontakiotis Theodoros, Balint Beatrix, Medgyasszay Balazs, Csanky Eszter, Bondarde Shailesh Arjun, Goyal Lovenish, Sharma Ajay, Balan Baijumon, Mohapatra Prabrajya Narayan, Patel Kaushalkumar Babubhai, Hingmire Sachin Sharadchandra, Shah Mithun Satish, Jain Kartikeya, Agrawal Ashish, Kumbhaj Prashant, Mukhopadhyay Asis, Khoueiry Paul, Yusak Suhana, Pang Yong Kek, Jye Voon Pei, Yehgambaram Prathepamalar, Ismail Fuad bin, Appalanaido Gokula Kumar, Barron Barron Feliciano, Uy Ma. Noemi, Martinez-Lapus Felycette Gay, Tamayo Maria Belen, Sandoval-Tan Jennifer, Osorio Sanchez Jamela Anne, Galvez Christina G., Contreras-Tolentino Josephine, Ledin Evgeny, Stroyakovskiy Daniil, Kudryavtsev Igor, Vladimirov Vladimir, Gotovkin Evgeniy, Shomova Marina, Mukhametshina Guzel, Lifirenko Igor, Karaseva Nina, Nechaeva Marina, Tarasova Anna, Luft Alexander, Kuzina Lyudmila, Petrovic Marina, Rancic Milan, Zaric Borjan, Buranachokphaisan Manoch, Geater Sarayut Lucien, Tharavichitkul Ekkapong, Gumus Mahmut, Bondarenko Igor, Shparyk Yaroslav, Shevnia Serhii, Lytvyn Iryna, Kolesnik Oleksii, Hotko Yevhen, Sinielnikov Ivan, Adamchuk Hryhoriy, Ursol Grygorii, Ivashchuk Oleksandr, Ostapenko Yuriy, Popovska Tetiana,
Funder
mAbxience Research SL
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference29 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. https://doi.org/10.3322/caac.21660. 2. Desai A, Gyawali B. Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions. E Clin Med. 2020;20:100269. 3. EMA. Avastin (bevacizumab). Summary of product characteristics 2021. https://www.ema.europa.eu/en/documents/product-information/avastin-epar-product-information_en.pdf. Accessed 24 Feb 2021. 4. FDA. Avastin® (bevacizumab) prescribing information. Genentech, Inc, 2021. https://www.gene.com/download/pdf/avastin_prescribing.pdf. Accessed 24 Feb 2021. 5. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Non-small cell lung cancer. Version 8.2020. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 18 Sep 2020.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|